Probe ECL could be activated by LAP with high sensitivity and excellent selectivity to emit NIR fluorescence. ECL-based fluorescence imaging of AKI achieved earlier diagnosis than serum marker determination and histological analysis of the kidneys. Furthermore, ECL was successfully used to monitor the progression of renal injury during breast cancer chemotherapy.
X. Xia, M. Huang, Z. Zhou, Y. Chen, P. Peng, E. Wang, F. Wang and J. Ren, Chem. Commun., 2026, 62, 4080 DOI: 10.1039/D5CC06544E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Please wait while we load your content...
